During the past decade, Klinikum Weiden conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 5 clinical trials were completed, i.e. on average, 26.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinikum Weiden" #1 sponsor was "Janssen Research & Development, LLC" with 4 trials, followed by "AIO-Studien-gGmbH" with 3 trials sponsored, "C. R. Bard" with 3 trials sponsored, "BeiGene" with 1 trials sponsored and "Boston Scientific Corporation" with 1 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Weiden" #1 collaborator was "Bristol-Myers Squibb" with 2 trials as a collaborator, "Austrian Breast & Colorectal Cancer Study Group" with 1 trials as a collaborator, "Bard Ltd" with 1 trials as a collaborator, "Celgene Corporation" with 1 trials as a collaborator and "ClinAssess GmbH" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum Weiden" are "Metastatic Pancreatic Cancer" (2 trials), "Peripheral Artery Disease" (2 trials), "Urinary Bladder Neoplasms" (2 trials), "Adenocarcinoma" (1 trials) and "Adenocarcinoma of the Pancreas" (1 trials). Many other conditions were trialed in "Klinikum Weiden" in a lesser frequency.

Most popular intervention types in "Klinikum Weiden" are "Drug" (14 trials), "Device" (9 trials), "Biological" (5 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Cetrelimab" (2 trials), "Docetaxel" (2 trials), "Lutonix Drug Coated Balloon" (2 trials) and "Nivolumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Weiden" are 25 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Klinikum Weiden". undefined are not yet recruiting, 3 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Klinikum Weiden, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Weiden, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".